Buy Zensar; target of Rs 1000: Motilal Oswal
I'm LongbridgeAI, I can summarize articles.Motilal Oswal recommends buying Zensar with a target price of Rs 1000. In Q3 FY26, Zensar's revenue fell 1.3% QoQ, while MCS grew 3.4%. The company reported a deal TCV of USD180m, with an EBIT margin of 16.0%. Adjusted PAT was INR2,191m, exceeding estimates. The outlook suggests EBITDA margins of 15.9%/16.2% for FY26/FY27, with a PAT CAGR of ~10% over FY26–28E. The target price is based on a 26x FY28E EPS valuation.
Motilal Oswal's research report on Zensar
Zensar (ZENT)’s 3QFY26 revenue declined 1.3% QoQ CC (vs. our est. of a 1.7% CC decline). MCS grew 3.4% QoQ CC, while TMT/HLS dipped 8.7%/2.3% QoQ CC. Deal TCV: Bookings came in at USD180m (up 14% QoQ/down 12% YoY), and the book-to-bill was 1.1x. EBIT margin was 16.0% (est. 14.3%), up 240bp QoQ. Adj. PAT of INR2,191m (up 20.3% QoQ/37.2% YoY) was above our estimate of INR1,798m. The adj. PAT excluded a one-time impact of costs related to labor codes amounting to INR254m.
Outlook
We expect EBITDA margins of 15.9%/16.2% for FY26/FY27, translating into a PAT CAGR of ~10% over FY26–28E. Our TP of INR 1,000 is premised on 26x FY28E EPS. We reiterate our BUY rating on the stock.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Zensar_27012026_Motilal Oswal